Zdrowie i gospodarka · 01/03/1994
International Conference on Harmonisation; Draft Guideline on the Extent of Population Exposure Required to Assess Clinical Safety for Drugs Intended for Long-Term Treatment of Non-Life-Threatening Conditions; Availability
The Food and Drug Administration (FDA) is publishing a draft guideline on the safety evaluation of drugs for long-term treatment of non-life-threatening conditions, prepared by the International Conference on Harmonisation's Expert Group on Efficacy.